• Login
    View Item 
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    •   UMB Digital Archive
    • UMB Open Access Articles
    • UMB Open Access Articles
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UMB Digital ArchiveCommunitiesPublication DateAuthorsTitlesSubjectsThis CollectionPublication DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Statistics

    Display statistics

    Consensus statement on the use of clozapine during the COVID-19 pandemic

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Author
    Siskind, D.
    Honer, W.G.
    Kelly, D.L.
    Date
    2020
    Journal
    Journal of psychiatry & neuroscience : JPN
    Publisher
    Canadian Medical Association
    Type
    Article
    
    Metadata
    Show full item record
    See at
    https://doi.org/10.1503/jpn.200061
    Abstract

    With the ongoing coronavirus disease 2019 (COVID-19) pandemic, psychiatrists find themselves in the clinical situation of being asked by patients, family members and patient advocacy societies to help ensure access to clozapine as a medication critical for ongoing patient care. To provide clozapine prescribing guidance and facilitate regulatory agencies modifying laboratory monitoring and/or dispensing requirements, an expert advisory subgroup of the Treatment Response and Resistance in Psychosis working group developed the following background, recommendations and rationale as a consensus statement.
    Keyword
    Coronavirus Disease 2019 (COVID-19)
    Clozapine
    Antipsychotic Agents
    Identifier to cite or link to this item
    https://www.scopus.com/inward/record.uri?eid=2-s2.0-85083188654&doi=10.1503%2fjpn.200061&partnerID=40&md5=0dc3ecc0fb112ea187d0e82342f634e5; http://hdl.handle.net/10713/12640
    ae974a485f413a2113503eed53cd6c53
    10.1503/jpn.200061
    Scopus Count
    Collections
    UMB Coronavirus Publications
    UMB Open Access Articles

    entitlement

    Related articles

    • Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.
    • Authors: Berk M, Fitzsimons J, Lambert T, Pantelis C, Kulkarni J, Castle D, Ryan EW, Jespersen S, McGorry P, Berger G, Kuluris B, Callaly T, Dodd S
    • Issue date: 2007
    • Clozapine--a perspective. Accepted as a consensus statement by the ACNP Council, August 13, 1990.
    • Authors: Shader RI
    • Issue date: 1991 Feb
    • The disquietude of clozapine continuation during the COVID-19 pandemic.
    • Authors: Shoib S, Bharati-Sinha V, Javed S, Gürcan A, Gürcan G, Das S, Chandradasa M, Saeed F
    • Issue date: 2022 Mar
    • Clozapine and COVID-19.
    • Authors: Silva E, Gee S, Smith S, Gaughran F
    • Issue date: 2020 Aug
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Policies | Contact Us | UMB Health Sciences & Human Services Library
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.